240 related articles for article (PubMed ID: 24548237)
21. siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.
Hattori Y; Nakamura T; Ohno H; Fujii N; Maitani Y
Int J Pharm; 2013 Feb; 443(1-2):221-9. PubMed ID: 23279939
[TBL] [Abstract][Full Text] [Related]
22. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
23. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
[TBL] [Abstract][Full Text] [Related]
24. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
Steele TW; Zhao X; Tarcha P; Kissel T
Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
[TBL] [Abstract][Full Text] [Related]
26. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
27. Structural exploration of hydrophobic core in polycationic micelles for improving siRNA delivery efficiency and cell viability.
Huang W; Wang X; Wang C; Du L; Zhang J; Deng L; Cao H; Dong A
J Mater Chem B; 2019 Feb; 7(6):965-973. PubMed ID: 32255101
[TBL] [Abstract][Full Text] [Related]
28. Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells.
Gu W; Jia Z; Truong NP; Prasadam I; Xiao Y; Monteiro MJ
Biomacromolecules; 2013 Oct; 14(10):3386-9. PubMed ID: 23992391
[TBL] [Abstract][Full Text] [Related]
29. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
30. Self-assembly of poly(allylamine)/siRNA nanoparticles, their intracellular fate and siRNA delivery.
Di Silvio D; Martínez-Moro M; Salvador C; de Los Angeles Ramirez M; Caceres-Velez PR; Ortore MG; Dupin D; Andreozzi P; Moya SE
J Colloid Interface Sci; 2019 Dec; 557():757-766. PubMed ID: 31569055
[TBL] [Abstract][Full Text] [Related]
31. Ring-opening polymerization for hyperbranched polycationic gene delivery vectors with excellent serum tolerance.
Zhang QF; Yu QY; Geng Y; Zhang J; Wu WX; Wang G; Gu Z; Yu XQ
ACS Appl Mater Interfaces; 2014 Sep; 6(18):15733-42. PubMed ID: 25177769
[TBL] [Abstract][Full Text] [Related]
32. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
Xiong XB; Uludağ H; Lavasanifar A
Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
[TBL] [Abstract][Full Text] [Related]
35. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery.
Herrero MA; Toma FM; Al-Jamal KT; Kostarelos K; Bianco A; Da Ros T; Bano F; Casalis L; Scoles G; Prato M
J Am Chem Soc; 2009 Jul; 131(28):9843-8. PubMed ID: 19555104
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
Bartlett DW; Davis ME
Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
[TBL] [Abstract][Full Text] [Related]
38. Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery.
Hendershot J; Smith AE; Werfel TA
J Vis Exp; 2019 May; (147):. PubMed ID: 31107463
[TBL] [Abstract][Full Text] [Related]
39. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
40. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Han J; Wang Q; Zhang Z; Gong T; Sun X
Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
